|
PPP2R5D expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.303020E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.793000E-01 |
| Normal-vs-Stage2 |
4.361000E-03 |
| Normal-vs-Stage3 |
1.608150E-02 |
| Normal-vs-Stage4 |
1.006840E-01 |
| Stage1-vs-Stage2 |
1.924070E-03 |
| Stage1-vs-Stage3 |
6.564000E-03 |
| Stage1-vs-Stage4 |
6.010100E-02 |
| Stage2-vs-Stage3 |
5.882400E-01 |
| Stage2-vs-Stage4 |
2.252400E-01 |
| Stage3-vs-Stage4 |
4.672400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.892000E-02 |
| Normal-vs-AfricanAmerican |
8.474600E-01 |
| Normal-vs-Asian |
6.084600E-01 |
| Caucasian-vs-AfricanAmerican |
3.545200E-01 |
| Caucasian-vs-Asian |
3.250000E-01 |
| AfricanAmerican-vs-Asian |
7.879200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.996100E-02 |
| Normal-vs-Female |
7.297200E-01 |
| Male-vs-Female |
5.010400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.795200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.172200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.986100E-02 |
| Normal-vs-Age(81-100Yrs) |
8.017100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.737200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.179400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.572400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.576570E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.053600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.718100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.588390E-02 |
| Normal-vs-Grade 2 |
5.694800E-01 |
| Normal-vs-Grade 3 |
1.764580E-01 |
| Normal-vs-Grade 4 |
6.802300E-04 |
| Grade 1-vs-Grade 2 |
1.078140E-02 |
| Grade 1-vs-Grade 3 |
2.973700E-04 |
| Grade 1-vs-Grade 4 |
4.41870000000844E-06 |
| Grade 2-vs-Grade 3 |
3.031400E-01 |
| Grade 2-vs-Grade 4 |
1.003510E-03 |
| Grade 3-vs-Grade 4 |
5.028100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.196400E-01 |
| Normal-vs-ccB subtype |
3.286100E-02 |
| ccA subtype-vs-ccB subtype |
5.298700E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.056400E-01 |
| Normal-vs-N1 |
2.397000E-01 |
| N0-vs-N1 |
6.303800E-01 |
|
|
